×
Aktuelle Nachrichten
NEW HOPE FOR THALASSAEMIA/SCD | UK Trial Of Lab Grown Red Blood Cells Begins
ADVANCED THERAPIES | Vertex, CRISPR To Submit Exa-Cel to FDA For β-Thalassaemia And Sickle Cell Disease
CDC | Many Children With Sickle Cell Anaemia In The US Not Receiving Lifesaving Screening And Treatment
CLINICAL NEWS | PYRUKYND® Receives Positive CHMP Opinion For The Treatment of PKD in Adults
NEWSLETTER | Iranian Blood Transfusion Organization (IBTO) August 2022
SAFER BLOOD | EU Patients Have Begun Receiving Transfusions With Hemanext ONE® RBC Processing & Storage System
WORLD PATIENT SAFETY DAY 2022 | Medication Without Harm: Know. Check. Ask.
SICKLE CELL DISEASE | African Health Ministers Launch Drive to Curb SCD’s Toll
A HISTORIC BREAKTHROUGH | UNICEF Signs First-Ever Malaria Vaccine Supply Contract With GSK
BREAKING NEWS | Bluebird’s Gene Therapy For β-Thalassaemia Wins US Approval
Deutsch
Italiano
العربية
English
Ελληνικά
Français
Deutsch
Menü
ÜBER UNS
SCHULUNGEN
LÄNDERSPEZIFISCHE ARBEIT
POSITIONEN UND RICHTLINIEN
PROJEKTE
VERÖFFENTLICHUNGEN
KONTAKT
Suchen nach
Startseite
/
AtRisk
AtRisk
Press Releases
Oktober 20, 2021
TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders
Weiterlesen »
Schaltfläche "Zurück zum Anfang"
Schließen
Suchen nach
